Results 101 to 110 of about 29,486 (214)

Potent and Long‐Lasting Immunogenicity Generated by LNP‐mRNA gE Antigen Against Varicella Zoster Virus via an AI‐Assisted Pipeline

open access: yesAdvanced Science, Volume 13, Issue 14, 9 March 2026.
This study designs a novel mRNA‐LNP vaccine targeting VZV glycoprotein E (gE) for herpes zoster via an AI‐assisted pipeline. Validated in mice and rhesus macaques, the mRNA‐LNP vaccine shows strong humoral and cellular immune responses, with CD4+ T‐cell responses more effective and durable than Shingrix, offering a promising prophylactic option ...
Kai Dong   +6 more
wiley   +1 more source

Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients [PDF]

open access: bronze, 2021
Alana F. Ogata   +10 more
openalex   +1 more source

Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS‐CoV‐2 Vaccination

open access: yesEuropean Journal of Immunology, Volume 56, Issue 3, March 2026.
Characterization of the early antigen‐specific B cell response post‐SARS‐CoV‐2 vaccination reveals novel activated B cell clusters, showing different phenotypes and contraction dynamics. Some short‐lived activated B cells expressed both CD71 and the extrafollicular marker CD11c.
Laura Fernandez Blanco   +23 more
wiley   +1 more source

Critical Evaluation of the Impact of COVID‐19 Pandemic on Child Health and Wellbeing and Suggested Preparedness for Future Pandemics–A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims The immediate and long‐term effects of COVID‐19 pandemic on the children go beyond just being a viral infection. A child's mental health and psychological issues like irritability, anxiety, sadness, non‐attentiveness, attention deficit and hyperactive disorder needed evaluation.
Ranjan K. Mohapatra   +20 more
wiley   +1 more source

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine

open access: gold, 2022
Abdulbaril Olagunju   +5 more
openalex   +1 more source

Différences d’immunogénicité des vaccins anti-SRAS-CoV-2 mRNA-1273 (Moderna) et BNT162b2 (Pfizer-BioNTech) chez les patients dialysés [PDF]

open access: gold, 2022
Kevin Yau   +21 more
openalex   +1 more source

Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV

open access: yesJournal of Microbiology, Immunology and Infection
Background: Real-world vaccine effectiveness following the third dose of vaccination against SARS-CoV-2 remains less investigated among people with HIV (PWH).
Wang-Da Liu   +26 more
doaj   +1 more source

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients [PDF]

open access: green, 2022
Matthias Becker   +19 more
openalex   +1 more source

Correction to: mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients [PDF]

open access: bronze, 2022
Nil Albiol   +11 more
openalex   +1 more source

Home - About - Disclaimer - Privacy